This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manosroi, J.
Right arrow Articles by Manosroi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manosroi, J.
Right arrow Articles by Manosroi, A.
Agricola
Right arrow Articles by Manosroi, J.
Right arrow Articles by Manosroi, A.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, June 2001, p. 2657-2664, Vol. 67, No. 6
0099-2240/01/$04.00+0   DOI: 10.1128/AEM.67.6.2657-2664.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Secretion of Active Recombinant Human Tissue Plasminogen Activator Derivatives in Escherichia coli

Jiradej Manosroi,1,2,* Chatchai Tayapiwatana,3 Friedrich Götz,4 Rolf G. Werner,5 and Aranya Manosroi1,2

Pharmaceutical Cosmetic Raw Materials and Natural Products Research and Development Center, Institute for Science and Technology Research and Development,1 and Department of Pharmaceutical Technology, Faculty of Pharmacy,2 and Department of Clinical Immunology, Faculty of Associated Medical Sciences,3 Chiang Mai University, 50200 Chiang Mai, Thailand, and Microbielle Genetik, Universität Tübingen, D-72076 Tübingen,4 and Boehringer Ingelheim Pharma KG, 88397 Biberach (Riss),5 Germany

Received 6 November 2000/Accepted 20 March 2001

The DNA fragment coding for kringle 2 plus serine protease domains (K2S) of tissue plasminogen activator (tPA) was inserted into a phagemid vector, pComb3HSS. In the recombinant vector, pComb3H-K2S, the K2S gene was fused to gpIII of Phi M13 and linked to the OmpA signal sequence. The resulting gene, rK2S-gpIII, was inducibly expressed in Escherichia coli XL-1 Blue. The protein was presented on the phage particle. To stop the expression of gpIII, a stop codon between K2S and the gpIII gene was inserted by site-directed mutagenesis. This mutated vector, MpComb3H-K2S, was transformed in XL-1 Blue. After induction with IPTG (isopropyl-beta -D-thiogalactopyranoside), rK2S was found both in the periplasm as an inactive form of approximately 32% and in the culture supernatant as an active form of approximately 68%. The secreted form of rK2S was partially purified by ammonium sulfate (55%) precipitation. The periplasmic form was isolated from whole cells by chloroform extraction. The fibrin binding site of kringle 2 was demonstrated in all expressed versions (phage-bound, periplasmic, and secreted forms) using the monoclonal anti-kringle 2 antibody (16/B). Only the secreted form of rK2S revealed a fibrinogen-dependent amidolytic activity with the specific activity of 236 IU/µg. No amidolytic activity of rK2S was observed in either the periplasmic or the phage-bound form. The secretion of rK2S as an active enzyme offers a novel approach for the production of the active-domain deletion mutant tPA, rK2S, without any requirements for bacterial compartment preparation and in vitro refolding processes. This finding is an important technological advance in the development of large-scale, bacterium-based tPA production systems.


* Corresponding author. Mailing address: Department of Pharmaceutical Technology, Faculty of Pharmacy, Chiang Mai University, 50200 Chiang Mai, Thailand. Phone: 66-53-894806 or 66-53-944338. Fax: 66-53-894169. E-mail: pmpti006{at}chiangmai.ac.th.


Applied and Environmental Microbiology, June 2001, p. 2657-2664, Vol. 67, No. 6
0099-2240/01/$04.00+0   DOI: 10.1128/AEM.67.6.2657-2664.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.